Clinical Trials List
2025-05-01 - 2028-07-31
Recruiting6
ICD-10C78.5
Secondary malignant neoplasm of large intestine and rectum
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9197.5
Secondary malignant neoplasm of large intestine and rectum
-
-
Trial Applicant
AbbVie
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 吳佳哲 Division of Hematology & Oncology
- 蔡宗翰 Division of Hematology & Oncology
- 林昶廷 Division of Hematology & Oncology
- 林偉雄 Division of Radiology
- Tai-Jan Chiu Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 常景棣 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Huang Chen Division of Hematology & Oncology
- 唐振育 Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- 吳紋綺 Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- 姜乃榕 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃怡璇 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Po-Wen Lin Division of General Surgery
- 詹仁豪 Division of General Surgery
- 陳柏全 Division of General Surgery
- Peng-Chan Lin Division of Hematology & Oncology
- 黃盈慈 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂嘉偉 Division of Radiology
- Wen-Chi Chou Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Jen-Shi Chen Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- 黃振洋 Division of Hematology & Oncology
- 賴盈傑 Division of Radiology
- Chia-Hsun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 梁逸歆 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- 陳柏邑 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- 李佳真 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- Ann-Lii Cheng Division of General Internal Medicine
- Chih-Hung Hsu Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- Ta-Ching Chen Division of Ophthalmology
- 莊建淮 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
390 participants
